99 related articles for article (PubMed ID: 8203037)
1. [What should be the role of antilipemic agents in the control of hypercholesterolemia in elderly persons?].
Champoux N; Latour J
Union Med Can; 1994 Feb; 123(2):91-4. PubMed ID: 8203037
[No Abstract] [Full Text] [Related]
2. [Assessment of hypolipemic action of the preparation olbetam in people with primary hypercholesterolemia].
Miturzyńska-Stryjecka H; Widomska-Czekajska T; Bielak G; Grossmann G
Wiad Lek; 1994 Aug; 47(15-16):566-9. PubMed ID: 7716950
[No Abstract] [Full Text] [Related]
3. [The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].
Union Med Can; 1994 Apr; 123(4):249-58. PubMed ID: 8203048
[No Abstract] [Full Text] [Related]
4. [Effect of hypolipemic agents on levels of total plasma homocysteine].
Dvoráková J; Dubská L; Táborský L; Hyánek J
Vnitr Lek; 2001 Oct; 47(10):674-7. PubMed ID: 11789004
[No Abstract] [Full Text] [Related]
5. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002.
Arnett DK; Jacobs DR; Luepker RV; Blackburn H; Armstrong C; Claas SA
Circulation; 2005 Dec; 112(25):3884-91. PubMed ID: 16344385
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hypercholesterolemia in the elderly].
Mulder WJ; Lavrijssen AT; Wolffenbuttel BH; Fiolet JF
Ned Tijdschr Geneeskd; 1995 Apr; 139(16):821-5. PubMed ID: 7731473
[No Abstract] [Full Text] [Related]
7. [Hypercholesterolemia and the diagnosis and management of hyper- lipidemia in adults. Recommendations of the working groups of the Finnish Society of Internal Medicine and the Finnish Cardiology Society].
Duodecim; 1988; 104(18):1425-38. PubMed ID: 3181045
[No Abstract] [Full Text] [Related]
8. Medication for hypercholesterolemia and the risk of nonfatal acute myocardial infarction: case-control study in Japan.
Circ J; 2002 May; 66(5):463-8. PubMed ID: 12030341
[TBL] [Abstract][Full Text] [Related]
9. [Controversies and advances in the treatment of hyperlipidemias].
Reza-Albarrán A; Aguilar-Salinas CA
Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
[No Abstract] [Full Text] [Related]
10. [Decisions regarding cholesterol-lowering therapy in the elderly: the experience in a lipid clinic and a review of the literature].
Garrido Sanjuán JA; Pía Iglesias G; González Moraleja J; Sesma P
An Med Interna; 1998 Jun; 15(6):305-10. PubMed ID: 9656510
[TBL] [Abstract][Full Text] [Related]
11. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
[No Abstract] [Full Text] [Related]
12. [Hypercholesterolemia, cardiovascular risk, and hypocholesteremic treatment in the elderly].
Cicconetti P; Ciotti V; Tafaro L; Riolo N; Marigliano V
Recenti Prog Med; 2002 Apr; 93(4):264-72. PubMed ID: 11989134
[TBL] [Abstract][Full Text] [Related]
13. [Medical recommendations and references about hypolipidemic drugs. ANDEM (National Agency for the Development of Medical Evaluation].
J Mal Vasc; 1997 Oct; 22(4):249-64. PubMed ID: 9411011
[No Abstract] [Full Text] [Related]
14. [Hypercholesterolemia: when and how much to treat it?].
Carmena R
Med Clin (Barc); 1983 Feb; 80(6):261-2. PubMed ID: 6865558
[No Abstract] [Full Text] [Related]
15. Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur studies of successful aging.
Karlamangla AS; Singer BH; Reuben DB; Seeman TE
J Am Geriatr Soc; 2004 Apr; 52(4):487-94. PubMed ID: 15066061
[TBL] [Abstract][Full Text] [Related]
16. Women with heart disease may need aggressive treatment for high cholesterol.
Int J Fertil Womens Med; 1997; 42(3):182. PubMed ID: 9222800
[No Abstract] [Full Text] [Related]
17. [Goal in hypercholesterolemia: lowering LDL cholesterol level by 50%].
MMW Fortschr Med; 2005 Jul; 147(27-28):51. PubMed ID: 16041948
[No Abstract] [Full Text] [Related]
18. [Secondary prevention of coronary heart disease with lipid lowering drugs. Evaluating outcome eliminates the controversy].
Pedersen TR
Internist (Berl); 1995 Dec; 36(12):1174-8. PubMed ID: 8567223
[No Abstract] [Full Text] [Related]
19. Treating hypercholesterolemia and hypertension based on lifetime global risk.
Kostis JB
Am J Cardiol; 2007 Jul; 100(1):138-42. PubMed ID: 17599456
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
Krempf M; Rohmer V; Farnier M; Issa-Sayegh M; Corda C; Sirugue I; Gerlinger C; Masseyeff-Elbaz MF
Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
